Michelle is one of three new masters students to join our group in 2018, her research will involve the development of anti-Alzheimer’s agents focused on targeting the catalytic triad and peripheral anionic site of acetyl cholinesterase as well as the development of kinase inhibitors targating tau hyperphosphorylation.

Contact details


Email: reinhartam@gmail.com

Linkedin: https://www.linkedin.com/in/michelle-reinhardt-2b0436124



Dr Darren Riley and Dr Jenny-Lee Panayides